Thoracic Drainage Devices Market: Clear Understanding of The Competitive Landscape and Key Product Segments

The global thoracic drainage devices market is expanding at a steady pace due to increase in incidences of pneumothorax and pleural effusion, adoption of advanced technological products such as digital thoracic drainage system and increase in cardiac surgical procedures among the geriatric population.

The global thoracic drainage devices market was valued over US$ US$ 555.8 Mn in 2016 and is projected to witness compound annual growth rate (CAGR) of over 6% from 2017 to 2025 to surpass the value of US$ 916.2 Mn by 2025.

Thoracic Drainage Devices Market Drivers

Key driving factors such as rise in patient preference for minimally invasive surgeries, high prevalence of cardiovascular diseases, increase in burden of spontaneous pneumothorax, and rise in health insurance coverage propelling adoption of thoracic drainage devices are the major factors that drives the growth of thoracic drainage devices market. Increase in number of open heart surgeries due to unhealthy lifestyle, lack of exercise, overweight, and smoking will create significant opportunities in the thoracic drainage devices market.

Request Sample to Know Quantitative Market Analysis, Current and Future Trends @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40529

Segmentation

The market for thoracic drainage devices market has been segmented broadly on the basis of different product type namely thoracic drainage system, trocar drain, unsecured needle, secured needle, pleural drainage catheter, and thoracic drainage kit. The market is further segmented into application type that includes thoracic surgery & pulmonology, cardiac surgery, general intensive care & emergency medicine, infectious disease, oncology & pain management, and military/damage control/disaster medicine. Thoracic drainage devices end-user segment includes ambulance services, hospitals & specialty clinics, urgent care or outpatient care, ambulatory surgery centers, and military surgeons. 

Applications

In terms of the application, thoracic surgery & pulmonology segment held the largest share. Thoracic and pulmonological disorders are quite common and increasing. Thoracic drainage devices are used in the treatment of pneumothorax, pleural effusions, and empyema disorders.

Future Scope

The health care market is likely to witness more transactions and consolidations in the next three to four years. One of the major factors driving the market is constantly rising insured population base. Expanding health insurance coverage is expected to increase demand for thoracic drainage device procedures. Patients with private coverage are more likely to seek medical treatment at an urgent care center or hospital settings. According to industry experts, favorable insurance coverage would influence the thoracic drainage devices market significantly by penetrating the sub-urban areas. These factors are expected to boost the growth of the thoracic drainage devices market

Get TOC of This Report @

https://www.transparencymarketresearch.com/report-toc/40529

North America and Europe contributed the highest share

By geography, global thoracic drainage devices market has been divided into major five region: North America, Europe, Asia, Latin America and Middle East & Africa. North America and Europe contributed the highest share of the global thoracic drainage devices market followed by Asia Pacific, Latin America, and Middle East & Africa. The U.S. dominated the thoracic drainage devices market in North America. This dominance is majorly due factors such as high cost of products and high level of end-user awareness. 

Key Players

The key players operating in the thoracic drainage devices market are Teleflex Incorporated, Vygon S.A., Medtronic plc., Cook Group Incorporated (Subsidiary: Cook Medical), C. R. Bard, Inc. (Becton, Dickinson and Company), MAQUET Holding B.V. & Co. KG (Getinge Group), Utah Medical Products, Inc., Smiths Medical, ATMOS MedizinTechnik GmbH & Co. KG, Sinapi Biomedical, and Medela.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.